
Crestchem (CRSTCHM) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
72.3M
Gross Profit
14.6M
20.25%
Operating Income
5.9M
8.10%
Net Income
6.1M
8.44%
Balance Sheet Metrics
Total Assets
105.4M
Total Liabilities
30.7M
Shareholders Equity
74.8M
Debt to Equity
0.41
Cash Flow Metrics
Revenue & Profitability Trend
Crestchem Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 250.8M | 212.6M | 166.3M | 79.5M | 75.1M |
Cost of Goods Sold | 187.6M | 161.0M | 144.4M | 61.3M | 58.2M |
Gross Profit | 63.1M | 51.5M | 21.9M | 18.2M | 16.9M |
Gross Margin % | 25.2% | 24.2% | 13.2% | 22.9% | 22.5% |
Operating Expenses | |||||
Research & Development | - | 1.1M | - | - | - |
Selling, General & Administrative | - | 4.6M | 2.8M | 2.3M | 1.2M |
Other Operating Expenses | 18.7M | 17.1M | 6.2M | 8.1M | 5.5M |
Total Operating Expenses | 18.7M | 22.8M | 9.0M | 10.4M | 6.7M |
Operating Income | 32.3M | 27.2M | 8.1M | 7.2M | 6.4M |
Operating Margin % | 12.9% | 12.8% | 4.8% | 9.1% | 8.5% |
Non-Operating Items | |||||
Interest Income | - | 2.5M | 1.4M | 753.6K | 541.8K |
Interest Expense | 130.0K | 62.0K | 143.0K | 158.0K | 148.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 36.6M | 29.8M | 9.4M | 7.8M | 6.7M |
Income Tax | 9.3M | 8.3M | 2.4M | 2.1M | 991.6K |
Effective Tax Rate % | 25.4% | 28.0% | 26.1% | 27.4% | 14.7% |
Net Income | 27.3M | 21.5M | 6.9M | 5.7M | 5.7M |
Net Margin % | 10.9% | 10.1% | 4.2% | 7.1% | 7.6% |
Key Metrics | |||||
EBITDA | 37.2M | 30.3M | 9.7M | 8.2M | 7.1M |
EPS (Basic) | - | ₹7.15 | ₹2.31 | ₹1.89 | ₹1.91 |
EPS (Diluted) | - | ₹7.15 | ₹2.31 | ₹1.89 | ₹1.91 |
Basic Shares Outstanding | - | 3001818 | 3000000 | 3001058 | 3000000 |
Diluted Shares Outstanding | - | 3001818 | 3000000 | 3001058 | 3000000 |
Income Statement Trend
Crestchem Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 7.3M | 1.5M | 8.7M | 96.6K | 345.3K |
Short-term Investments | - | - | - | - | 9.4M |
Accounts Receivable | 25.6M | 15.3M | 163.6K | 9.0M | 14.1M |
Inventory | 3.0K | 0 | 0 | 25.0K | 31.2K |
Other Current Assets | 10.2M | 20.3K | 20.3K | 20.3K | 20.3K |
Total Current Assets | 43.1M | 22.9M | 12.1M | 11.8M | 27.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | - | 309.6K | 309.6K | 309.6K | 309.6K |
Goodwill | - | 0 | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 751.0K | 751.0K | 751.0K | 751.0K | 751.0K |
Total Non-Current Assets | 62.4M | 48.6M | 35.7M | 21.2M | 3.0M |
Total Assets | 105.4M | 71.4M | 47.9M | 32.9M | 30.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 19.0M | 12.7M | 17.4M | 7.0M | 3.8M |
Short-term Debt | 0 | 0 | 0 | 2.7M | 6.3M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 780.0K | 949.0K | 355.0K | 499.0K | 874.0K |
Total Current Liabilities | 30.0M | 22.1M | 20.2M | 12.3M | 14.6M |
Non-Current Liabilities | |||||
Long-term Debt | - | - | - | - | - |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 61.6K |
Other Non-Current Liabilities | - | 1 | -1 | 1.0K | -10 |
Total Non-Current Liabilities | 714.0K | 353.6K | 137.3K | 64.0K | 495.9K |
Total Liabilities | 30.7M | 22.4M | 20.3M | 12.3M | 15.1M |
Equity | |||||
Common Stock | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M |
Retained Earnings | - | 19.0M | -2.5M | -9.4M | -15.1M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 74.8M | 49.0M | 27.5M | 20.6M | 14.9M |
Key Metrics | |||||
Total Debt | 0 | 0 | 0 | 2.7M | 6.3M |
Working Capital | 13.1M | 789.6K | -8.1M | -511.2K | 12.4M |
Balance Sheet Composition
Crestchem Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 36.6M | 29.8M | 9.4M | 7.8M | 6.7M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -14.5M | -12.0M | 5.4M | 1.6M | 3.6M |
Operating Cash Flow | 17.8M | 15.3M | 13.5M | 8.8M | 10.0M |
Investing Activities | |||||
Capital Expenditures | 0 | 0 | 0 | 0 | -3.5M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -12.9M | -12.0M | -37.4M | -18.4M | -366.9K |
Investment Sales | - | 142.0M | 22.7M | 9.4M | - |
Investing Cash Flow | -12.9M | 129.9M | -14.6M | -9.0M | -4.2M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -747.0K | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | -747.0K | - | - | - | - |
Free Cash Flow | 15.2M | 2.3M | 21.9M | 8.2M | -150.7K |
Net Change in Cash | 4.2M | 145.3M | -1.1M | -220.0K | 5.7M |
Cash Flow Trend
Crestchem Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
13.74
Price to Book
5.01
Price to Sales
1.50
Profitability Ratios
Profit Margin
9.94%
Operating Margin
9.13%
Return on Equity
36.47%
Return on Assets
25.86%
Financial Health
Current Ratio
1.44
Debt to Equity
0.00
Per Share Data
EPS (TTM)
₹9.08
Book Value per Share
₹24.92
Revenue per Share
₹83.05
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
crstchm | 374.2M | 13.74 | 5.01 | 36.47% | 9.94% | 0.00 |
Asian Paints | 2.4T | 67.58 | 12.50 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.94 | 16.09 | 20.85% | 16.16% | 4.56 |
Tanfac Industries | 46.6B | 48.54 | 14.95 | 32.50% | 15.83% | 13.28 |
Kingfa Science | 46.2B | 30.12 | 6.35 | 20.98% | 8.58% | 5.90 |
Grauer & Weil | 42.1B | 26.73 | 4.48 | 16.73% | 13.35% | 1.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.